You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
陽普醫療(300030.SZ):預計2023年淨虧損4500萬元–6500萬元
格隆匯 01-30 18:30

格隆匯1月30日丨陽普醫療(300030.SZ)公佈,預計2023年淨虧損4,500萬元–6,500萬元,扣非淨虧損5,300萬元–7,300萬元。

報吿期內,公司預計營業收入約6.41億元,比上年同期7.11億元下降0.70億元,下降比例為9.85%。其中真空採血管理系統預計實現收入3.81億元,與上年同期基本持平;微生物轉運系統市場需求大幅減少,預計實現收入約372.73萬元,比上年同期減少4,533.67萬元,減少比例為92.40%;儀器設備預計實現收入2,484.69萬元,比上年同期減少2,813.38萬元,減少比例53.10%。

報吿期內,公司對2023年度末可能發生減值跡象的資產進行了全面清查和資產減值測試,預計2023年計提各項資產減值準備及計提信用減值損失合計約2,000.00萬元,比上年同期減少10,859.24萬元;預計公允價值變動收益約-300.00萬元,比上年同期增加295.34萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account